Karyopharm Therapeutics Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 4.51 | 558,243 | 2,515,834 | 6,149,624 | 6.7 M to 6.1 M (-8.32 %) |
| Feb 27 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 5.00 | 123,400 | 617,210 | 6,707,867 | 6.8 M to 6.7 M (-1.81 %) |
| Feb 27 2019 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 4.99 | 800,000 | 3,994,880 | 6,831,267 | 7.6 M to 6.8 M (-10.48 %) |
| Feb 25 2019 | KPTI | Karyopharm Therape ... | Mason Michael | SVP, CFO & Treasure ... | Option Exercise | A | 5.06 | 150,000 | 759,000 | 150,000 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Peters Cameron | VP of Finance | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Peters Cameron | VP of Finance | Option Exercise | A | 9.21 | 17,000 | 156,570 | 17,000 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Varadan Anand | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 38,700 | 0 | 38,700 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Varadan Anand | EVP, Chief Commerci ... | Option Exercise | A | 9.21 | 102,800 | 946,788 | 102,800 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 0.00 | 38,700 | 0 | 38,700 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 9.21 | 102,800 | 946,788 | 102,800 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 0.00 | 87,200 | 0 | 87,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 | |
| Feb 19 2019 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 9.21 | 231,200 | 2,129,352 | 231,200 |